Acerus Pharmaceuticals Q3 EPS $(0.02) Down From $(0.01) YoY

Acerus Pharmaceuticals (TSX:ASP) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.

Benzinga · 11/14/2019 12:12

Acerus Pharmaceuticals (TSX:ASP) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year.